You are here » Home » Companies » Company Overview » Brooks Laboratories Ltd

Brooks Laboratories Ltd.

BSE: 533543 Sector: Health care
NSE: BROOKS ISIN Code: INE650L01011
BSE LIVE 15:40 | 02 Dec 141.70 -4.30
(-2.95%)
OPEN

143.65

HIGH

145.00

LOW

141.00

NSE LIVE 15:30 | 02 Dec 141.95 -3.70
(-2.54%)
OPEN

144.00

HIGH

145.45

LOW

141.00

OPEN 143.65
PREVIOUS CLOSE 146.00
VOLUME 13538
52-Week high 194.40
52-Week low 68.75
P/E 23.78
Mkt Cap.(Rs cr) 229.41
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 143.65
CLOSE 146.00
VOLUME 13538
52-Week high 194.40
52-Week low 68.75
P/E 23.78
Mkt Cap.(Rs cr) 229.41
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

About Brooks Laboratories Ltd.

Brooks Laboratories Ltd

Brooks Laboratories Ltd is a Pharmaceutical Contract Research & Manufacturing Services company. The company has a wide range of products catering to critical care segment in Parental Section like Beta Lactam, Cephalosporin & General Dry powder Injectables, Ampoules and Liquid vials, Dry Syrups and Tablets etc. Their product portfolio presently comprises of 28 Injectables, 19 Tablets and 2 Dry Syru...> More

Brooks Laboratories Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   229
EPS - TTM () [*S] 5.96
P/E Ratio (X) [*S] 23.78
Face Value ()   10
Latest Dividend (%)   -
Latest Dividend Date -
Dividend Yield (%) 0.00
Book Value / Share () [*S] 76.85
P/B Ratio () [*S] 1.84
[*C] Consolidated     [*S] Standalone

Brooks Laboratories Ltd - Financial Results

Particulars ( cr) Sep 2016 Sep 2015 % Chg
Net Sales 13.73 20.47 -32.93
Other Income 0.03 0.44 -93.18
Total Income 13.76 20.91 -34.19
Total Expenses 12.04 17.8 -32.36
Operating Profit 1.72 3.11 -44.69
Net Profit 0.73 1.7 -57.06
Equity Capital 16.19 16.19 -
> More on Brooks Laboratories Ltd Financials Results

Brooks Laboratories Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
Orchid Pharma 29.00 -3.01 257.98
Jenburkt Pharma 525.90 -1.07 244.54
Piraml.Phyto. 93.20 -3.47 241.95
Brooks Lab. 141.70 -2.95 229.41
Mangalam Drugs 141.30 -2.82 223.68
Kopran 51.35 -4.91 222.09
Coral Labs. 602.40 0.40 215.06
> More on Brooks Laboratories Ltd Peer Group

Brooks Laboratories Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 60.62
Banks/FIs 0.34
FIIs 0.00
Insurance 0.00
Mutual Funds 0.00
Indian Public 25.80
Custodians 0.00
Other 13.25
> More on Brooks Laboratories Ltd Share Holding Pattern

Brooks Laboratories Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week 8.54% 8.94% -0.33% -0.34%
1 Month -20.93% -20.94% -4.71% -5.02%
3 Month 17.11% 15.92% -8.07% -8.21%
6 Month 77.13% 78.89% -2.28% -1.61%
1 Year 50.27% 50.93% 0.43% 1.96%
3 Year 707.41% 711.14% 25.52% 30.06%

Brooks Laboratories Ltd - STOCK STRENGTH

Today's Low/High 141.00
145.00
Week Low/High 124.00
154.00
Month Low/High 117.00
187.00
YEAR Low/High 68.75
194.00
All TIME Low/High 12.50
194.00

Upgrade To Premium Services

Welcome User

Business Standard is happy to inform you of the launch of "Business Standard Premium Services"

As a premium subscriber you get an across device unfettered access to a range of services which include:

  • Access Exclusive content - articles, features & opinion pieces
  • Weekly Industry/Genre specific newsletters - Choose multiple industries/genres
  • Access to 17 plus years of content archives
  • Set Stock price alerts for your portfolio and watch list and get them delivered to your e-mail box
  • End of day news alerts on 5 companies (via email)
  • NEW: Get seamless access to WSJ.com at a great price. No additional sign-up required.
 

Premium Services

In Partnership with

 

Dear Guest,

 

Welcome to the premium services of Business Standard brought to you courtesy FIS.
Kindly visit the Manage my subscription page to discover the benefits of this programme.

Enjoy Reading!
Team Business Standard